Proteintech / ChromoTek GmbH

Proteintech / ChromoTek GmbH is a company that pioneers a new class of immunologic research tools derived from single-domain camel antibodies for cell biology and proteomics. Founded in 2008, the company has rapidly developed into a renowned supplier of innovative reagents and a trusted service provider for big pharma. Their management team combines complementary skills and experiences, forming a basis for sustained growth. Proteintech / ChromoTek GmbH's mission is to develop and commercialize better tools for research around the world, with a vision to become the most recognized leader in the fields of proteomics and live cell imaging. The company offers various products, including Nano-Traps, Boosters, and Chromobodies, which are designed to enhance the specificity and efficiency of research experiments.

ChromoTek GmbH pioneers a new class of immunologic research tools derived from single domain camel antibodies for cell biology and proteomics. Founded in 2008 as a spin-off from the Ludwig-Maximilians University Munich (LMU) by a research team around Ulrich Rothbauer, ChromoTek has rapidly developed to become a renowned supplier of innovative reagents as well as a trusted service provider for big pharma. Our management team combines complementary skills and experiences that form a basis for sustained growth.

Our mission is to develop and commercialize better tools for our customers research around the world. With a series of products and services under development, our vision is to become the most recognized leader in the fields of proteomics and live cell imaging.

ChromoTek offers innovative research reagents based on Camelid antibodies: Our Nano-Traps are perfect tools for the rapid immuno- precipitation of proteins and their interaction partners with high specificity and efficiency. Our Boosters enhance the signal intensity of your targets in fluorescent microscopy. And our recently introduced Chromobodies® allow you to analyze endogenous proteins in living cells in real time. In addition, we provide a growing number of exceptionally specific conventional antibodies.

Last not least, our new fluorescent 2-hybrid (F2H®) assay enables you to monitor reversible protein-protein interactions in a cellular system.